These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review. Dwivedi J, Sharma S, Jain S, Singh A. Mini Rev Med Chem; 2018; 18(11):918-947. PubMed ID: 28971774 [Abstract] [Full Text] [Related]
3. The 5-HT6 receptor as a target for developing novel antiobesity drugs. Heal D, Gosden J, Smith S. Int Rev Neurobiol; 2011; 96():73-109. PubMed ID: 21329785 [No Abstract] [Full Text] [Related]
8. [Ligandomics--a tool for the development of targeted treatments]. Porkka K, Laakkonen P. Duodecim; 2002 Dec 06; 118(11):1185-92. PubMed ID: 12239852 [No Abstract] [Full Text] [Related]
17. [Indications for antineoplastic effects of nonsteroidal anti-inflammatory drugs]. Kooy A, Splinter TA, Wilson JH. Ned Tijdschr Geneeskd; 1995 Nov 04; 139(44):2235-9. PubMed ID: 7501050 [No Abstract] [Full Text] [Related]
18. Venom Peptides: Improving Specificity in Cancer Therapy. Mahadevappa R, Ma R, Kwok HF. Trends Cancer; 2017 Sep 04; 3(9):611-614. PubMed ID: 28867164 [Abstract] [Full Text] [Related]
19. Virtual screening against obesity. Markt P, Herdlinger S, Schuster D. Curr Med Chem; 2011 Sep 04; 18(14):2158-73. PubMed ID: 21517763 [Abstract] [Full Text] [Related]